Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications.
about
Expression of the autoimmune regulator gene and its relevance to the mechanisms of central and peripheral toleranceClinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyPrimary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestationsIL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A TherapiesMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyLymphopenia-induced proliferation in aire-deficient mice helps to explain their autoimmunity and differences from human patientscFLIP overexpression in T cells in thymoma-associated myasthenia gravisClinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasisHosting infection: experimental models to assay Candida virulenceAPECED: is this a model for failure of T cell and B cell tolerance?Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.Absence of some common organ-specific and non-organ-specific autoimmunity in autoimmune polyendocrinopathy candidiasis ectodermal dystrophyMolecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.Immunity to infection in IL-17-deficient mice and humansHuman APECED; a Sick Thymus Syndrome?Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome.TH17 deficiency in human disease.Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model.Modern management of primary T-cell immunodeficiencies.Detection of anti-cytokine antibodies and their clinical relevance.Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders.AIRE expands: new roles in immune tolerance and beyond.The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.Genetic Predictors of Susceptibility to Dermatophytoses.Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications.Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins.AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating AutoantibodiesAutoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked.Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity.The Role of Human IL-17 Immunity in Fungal Disease
P2860
Q21296698-76F89A50-06A0-46F0-B500-C58C3F14EB4AQ26765172-08C77A30-58A2-4A99-A138-57BE7AA53318Q26830870-3BB85AFC-51DC-4817-B7F2-DCA29B4DA5DAQ26830943-13A198E8-F752-4BF4-A193-ED174B9F668FQ27010562-3A5409B5-7DA3-4793-A554-9883D10574C8Q27014040-5C2DBE58-DC33-4B83-833C-E18BEDF891D6Q28389001-B9447638-F4E0-43FC-B407-2079E1ECDB9DQ34310349-193B8D88-1364-4E87-ACEA-0C8C0694408AQ35568424-BF9685DA-EFCA-4CF9-A96F-6EAE67A3368DQ35659934-C50B9DF0-B499-4DFA-8220-6C702A93770FQ36135322-4CB04DBA-FEC8-4060-823E-99260626BEB0Q36512728-80B099FA-EAAB-4732-8A4B-BB8A6EEA87F0Q36924530-C4DE14E6-AD0F-4BF8-9CF1-6E40960AC779Q36989715-8D76934A-DF37-4852-8661-1E8E5ED3F182Q37037708-F0FA2943-0A13-40D0-AD0C-4262D4DED8CBQ37217551-5BA53AAD-2619-4D6B-B964-86B28F4B8C3AQ37538514-F083FA54-CD22-48C6-B56F-220265C34C2CQ37974985-551DEF20-D743-4E2F-9A09-B48FC10B5F43Q38007258-17A3AC2F-2B37-416D-81A4-6C4970B09BC7Q38068960-F1B43D60-C757-45A0-8AE7-2ADCEA4AAB02Q38175191-3672AE5A-7852-4846-8BC4-F5AD6CBFF6E6Q38217701-CE172B3D-8EF1-4AD4-ADCD-A1B66663CC38Q38542575-0B9ACE44-BC32-4750-904D-B605FF2964D6Q38558955-CAE89AD1-CD8B-4BE9-A432-56487F3426DFQ38773105-014EFBC1-41E8-4CCD-888A-4ED2AD26F855Q39344161-7FD7A1B0-4E53-4D63-BE67-09FB81BE9774Q39511094-44DC9C6B-102D-4697-B0DC-592283135257Q41365452-C6503339-2815-469B-9BF6-26E9F2ADA795Q41449614-61DB6FD2-1700-4AC9-8605-DAFE39D423B7Q41819064-21849C12-48B5-4A39-9CD4-8493CB9F6C46Q42229891-A2A932AF-3324-4B0C-A65F-56A0E65210A6Q45212464-81507F8A-5EF2-460E-A53E-4AEEF7B2A4E8Q52719679-6F0E508E-4DB0-49E5-9E48-E72D39BCA939Q54698008-6D92FF67-2049-417C-9C92-DBCB5F43E46DQ55259964-E584D1CB-5989-4605-83E9-8F5505F08513Q56939724-CA1ACFC1-2D19-4B9E-8022-9477C481CC38
P2860
Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@en
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@nl
type
label
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@en
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@nl
prefLabel
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@en
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@nl
P2093
P2860
P50
P356
P1476
Mucocutaneous candidiasis and ...... and pathogenetic implications.
@en
P2093
Anthony Meager
Desa Lilic
Nick Willcox
P2860
P304
P356
10.1002/EJI.201041253
P407
P577
2011-05-13T00:00:00Z